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Staphylococcal nuclease is a  convenient model antigen for study of the ge- 
netics of the antibody response partly because of the large amount of informa- 
tion available about its chemistry and because of its relative simplicity among 
natural protein antigens. However, we have shown in the accompanying paper 
(1) that even for nuclease the interpretation of  the genetic control of  the immune 
response becomes complex after several immunizations. In contrast, we showed 
that for at least one peptide fragment of nuclease (99-149) as immunogen, the 
response pattern was the same as the initial response to the native protein but 
without the complexities which arose after repeated immunizations. 
To explore further the complexities in the response to staphylococcal nuclease, 
and in particular the ability of the low responder C57BL/10 strain to increase in 
response with boosting to the level of antinuclease production of the congenic 
high responder B10.A,  we have  studied the  specificities of antibodies which 
comprise the anti-whole nuclease sera, in these two strains as well as the A/J 
and SJL strains. Both initial and hyperimmune responses were examined. The 
question explored was whether low responders were uniformly low across the 
spectrum of specificities produced to the complex antigen, or whether they were 
selectively low responders to some specificities on the antigen molecule and not 
to others. We found the latter to be the case, at least for the C57BL/10 response 
to nuclease,  indicating that H-2-1inked Ir genes can control the antibody re- 
sponse to different determinants on the same antigen molecule separately from 
one another. One implication is the function ofH-2-1inked Ir genes at the level 
of the selection of specific B cells. 
Materials and Methods 
Mice.  Mice were purchase from The Jackson Laboratory, Bar Harbor,  Maine. Four strains 
were studied: high responders A/J (H-2")  and SJL/J (/-/-2'), intermediate responder B10.A/SgSn 
(H-2"), and low responder C57BL/10  Sn (H-2b). All mice were male except the SJL strain. All were 
6-8-wk old at the start of each experiment. 
Immunization Schedule.  Mice were immunized i.p. with 100/zg of nuclease emulsified 1:1 in 
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complete Freund's adjuvant, and bled and boosted as previously described (1).  Blood from 8-12 
mice of each strain was pooled, and studies were all performed on pooled sera. 
Highly Purified Staphylococcal Nuclease.  Nuclease was purified by the method of Bohnert and 
Taniuchi  (2).  Because of the extraordinary sensitivity of immune systems to potential highly 
immunogenic albeit chemically minor contaminants in antigens, particular care was taken to 
insure the high purity of the nuclease used. The initial product had two faint bands on either side 
of the main band on polyacrylamide gel electrophoresis (7% acrylamide gels pH 9.5 run in Tris- 
(6 g/liter) glycine (29.9 g/liter) buffer at pH 8.4 at 4°C with reverse polarity). Therefore, the enzyme 
was further purified by phosphocellulose chromatography (41 mg applied to a 4-ml phosphocellu- 
lose column and eluted at room temperature with a linear gradient of ammonium acetate from 0.3 
M, pH 5.7, to 1.0 M, pH 8.0. The resulting preparation (72% yield, sp act 2,400 U/mg) showed only 
the faint slower-moving band in addition to the main band on polyacrylamide gel electrophoresis. 
On sodium dodecyl sulfate gel electrophoresis (3) the molecular weight of the faint second band 
was estimated to be twice that of nuclease, consistent with its being a  dimer as noted on gel 
filtration (2). This preparation showed only a single line on Ouchterlony double immunodiffusion 
against several goat antinuclease sera made to highly purified and partially purified nuclease. 
Assay of Antibodies  to Nuclease by Inhibition of Enzymatic Activity.  The assay for antinu- 
clease has been described previously (1). The ability to inhibit 1 U of nuclease activity is defined as 
1 inhibition U and corresponds to 32.8 pmol of antibody binding sites. 
Radioimmunoassay for Antibodies Binding to Labeled Fragments of Nuclease.  To assess the 
specificities of antibody populations in antisera raised to native nuclease, binding to 14C-labeled 
fragments was  measured by  a  method modified from that used to  assay  antibodies raised to 
fragments of nuclease described in the accompanying paper (1). This approach was feasible even 
though antibodies raised to native nuclease have been found to be specific  for the native conforma- 
tion of the molecule rather than the random conformations of the fragments, since binding of the 
fragments can be described by a model in which the fragments exist in a conformational equilib- 
rium between random and native conformations (e.g., 0.02%  native for fragment [99-149])  (4). 
Since the apparent affinities for fragments are thus lower by three-to-four orders of magnitude, 
only  relatively  high  affinity anti-native nuclease  antibodies can  be  measured by  binding to 
fragments.  1 
The radioimmunoassay protocol (1) was modified in that whole binding curves were done for 
each serum studied, and increasing concentrations of 14C-labeled fragments of nuclease (from 0.1 
to 20  t~M) were added first rather than serum. Dilutions of the labeled fragments were made in 
phosphate-buffered  saline containing 1.6 mg/ml of goat gamma globulin fraction II (Miles Labora- 
tories Inc., Elkhart, Ind. 82-572, lot 13) to avoid losses on vessel walls at high dilution. For each 
concentration of antigen, binding by preimmune serum was also measured and subtracted. 
ConcentrationS of antibodies of a  given specificity were obtained from the intercepts of Scat- 
chard  plots  for binding to  the  appropriate fragments,  or  from plateau  binding in  saturation 
binding curves. 
Separation  of IgM and IgG Classes  of Immunoglobulin.  Approximately 1 ml of serum was 
passed over a previously calibrated 1.5 x  95-cm column of Sephadex G-200 in 0.15 M saline at room 
temperature at a flow rate of 6 ml/h. Fractions corresponding in size to IgM and IgG were pooled 
and concentrated by vacuum dialysis in  a  collodion bag against saline,  and were assayed for 
binding activity. 
Results 
To understand which determinants of staphylococcal nuclease are involved in 
the antibody response to whole (native) nuclease by different strains of mice, we 
In view of this important conformational effect, and since the antibodies remained active in 
the presence of polyethylene glycol before centrifugation to separate phases, it was important to 
show that polyethylene glycol did not increase the folding of the random conformation fragments. 
Polyethylene glycol at 12.5% wt:wt did not increase the helicity of fragment (99-149) assessed by 
circular dichroism, whereas this region of native nuclease has two of the three a-helical segments 
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FIG.  1.  Scatchard analysis of the binding of A/J and SJL hyperimmune antinuclease to 
14C-fragment (99-149). Radioimmunoassay titration was performed as described in Materi- 
als and Methods. Final dilution  of whole antiserum in all tubes was 1:5. (D) serum pooled 
from 22 A/J mice after five immunizations with native nuclease;  (*) serum pooled from 14 
SJL mice after five immunizations with native nuclease.  Each point represents the differ- 
ence between the mean of duplicates  for the immune serum and that for the corresponding 
preimmune serum. 
measured specificities of the mixtures of antibodies produced by immunization 
with nuclease. 
Binding  to  Fragment  (99-149)  by  Hyperimmune  Antinuclease  Sera  from 
High Responder A/J and SJL Mice.  Scatchard analysis of the binding of 14C- 
fragment (99-149) by antinuclease sera from these two highest responder strains 
(Fig.  1)  shows  almost  superimposable  binding  curves  for  A/J  and  SJL  sera. 
Thus,  both  the  affinities  and  the  concentrations  of the  mixture  of different 
antibodies made to determinants in this subregion of nuclease are similar in the 
two  strains.  This  result  contrasts  with  the  finding  that  the  predominant  idi- 
otypes of the antibodies to nuclease made by A/J and SJL mice were distinct (6). 
However, the antibodies detected to this subregion represent only 10-20% of the 
total antinuclease  antibodies,  so the idiotypic antisera may be detecting  other 
antibodies.  Alternatively,  comparable binding  sites  may not require  identical 
variable regions. 
Binding  to Fragment  (99-149)  by Initial  and Hyperimmune  Antinuclease 
Sera from Congenic C57BL/10 and BIO.A Mice.  A  similar analysis was used 
to compare the fraction of total antinuclease  which bound to the fragment (99- 
149)  in sera from the congenic C57BL/10 and B10.A strains  (Fig.  2).  Scatchard 
analysis of the data showed that a  2:5 dilution of the first-bleed serum from the 
B10.A mice,  3  wk  after a  single  i.p.  immunization  with  nuclease in  complete 
Freund's adjuvant,  had a  0.1-0.2  ~M concentration of binding sites specific for 126 
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FIG. 2.  Scatchard analyses  of the binding of C57BL/10 and B10.A antinuclease  to  ~4C- 
fragment (99-149). (x) serum pooled from seven C57BL/10 mice; (O) serum pooled from nine 
B10.A mice. Curves are hand-drawn approximations to the data points.  Left panel, first- 
bleed sera drawn 21 days after a single intraperitoneal immunization of native nuclease in 
complete Freund's adjuvant and diluted 2:5 in all tubes. Right panel, hyperimmune sera 
drawn after five immunizations with native nuclease,  and used diluted 1:5 in all tubes. 
fragment  (99-149).  In  contrast,  no  detectable  binding  to  this  fragment  was 
observed for the corresponding serum from the C57BL/10  strain. 
When the hyperimmune sera,  after five immunizations with nuclease,  were 
similarly compared for the two strains (Fig. 2, right panel), measurable binding 
to fragment (99-149) was detected for the C57BL/10 sera, but the concentration of 
sites specific for this region was threefold lower than that of the B10.A sera. The 
threefold  difference  was  confirmed  in  the  saturation  curves  for  binding  of 
fragment (99-149) by the same sera (not shown). Thus, although the initial low 
responder C57BL/10  appeared to reach the same level  of response  as the high 
responder  B10.A  after  multiple  boosts when  only the  overall  concentration  of 
antibodies to whole nuclease was measured (1), the concentration of antibodies 
specific for region (99-149) in these same sera never reached the same level as in 
the B10.A.  With repeated immunizations, the distinction between high and low 
responder disappeared  in  an assay that measured only the overall response to 
the whole complex antigen, but remained in an assay that selectively measured 
antibodies to a  more restricted region of the antigen. 
This marked difference  in  response to nuclease  when antibodies  specific  for 
the fragment  (99-149) were assessed was reproducible in a  completely separate 
group  of  mice  immunized  at  a  later  time.  By  the  third  immunization,  the 
C57BL/10  response  to  whole  nuclease  (about  88  inhibition  U/ml  serum)  had 
actually  surpassed  that  of the  B10.A  (about  50  inhibition  U/ml  serum),  even BERZOFSKY,  SCHECHTER,  SHEARER,  AND  SACHS 
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FIo.  3.  Binding  of ~4C-fragment (99-149) by hyperimmune sera from a second group of 
C57BL/10 and B10.A mice. Sera were drawn after three immunizations with native nu- 
clease  and  used  in  a  final  dilution  of 1:5. (x)  sera  pooled from five C57BL/10 mice, 
antinuclease titer 88 inhibition U/ml; (O) sera pooled from nine B10.A mice, antinuclease 
titer 50 inhibition U/mt. 
though  the  initial  response  was  much  lower  for  the  C57BL/10  than  for  the 
B10.A.  In contrast,  no binding to the  fragment  (99-149)  was detectable  in  the 
C57BL/10  third  bleed  serum,  compared  with  about  1.5  /~M  antibody  binding 
sites specific for this region in the B10.A serum (Fig.  3).  Thus,  even when the 
C57BL/10  response to  nuclease had  surpassed that  of the  B10.A  animals,  the 
production of antibodies to the 99-149 region by the C57BL/10 animals remained 
undetectable. 
Binding to Fragment (1-126) by Initial and Hyperimmune Antinuclease Sera 
from  Congenic  C57BL/10  and  BIO.A  Mice.  In  contrast  to  the  binding  to 
fragment  (99-149),  the  concentration  of  antinuclease  antibodies  specific  for 
determinants  in  the  1-126  region  appeared  to  be  about  the  same  in  the  two 
strains.  This  equality held for both  the  initial  antinuclease  sera 3  wk after a 
single immunization  in  complete Freund's adjuvant  (Fig.  4)  and the hyperim- 
mune antinuclease sera after five immunizations (curve not shown; see Table I). 
The concentrations  of antibody binding  sites was higher  in  all cases than the 
binding to fragment  (99-149).  This result is not surprising,  since fragment  (1- 
126) represents a  much larger part of the nuclease molecule than fragment (99- 
149)  and overlaps the latter from residues 99 to 126. 
Relative Proportions of Antibodies Specific for Regions of Nuclease in Anti- 
sera to Whole Nuclease.  The concentrations of antibodies binding to different 
labeled fragments of nuclease,  expressed as micromolar antibody binding sites 
in undiluted serum, are summarized in Table I. The right-hand column lists the 
ratio of antibodies specific for the two fragments of nuclease in the same sera, 
made to native nuclease. 128 
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FIG.  4.  Binding  of  057BL/10  and  B10.A  primary  antinuclease  to  ~4C-fragment  (1-126). 
Sera  are  those  described  in Fig.  2  (left panel),  used  at  a  1:5 final  dilution.  (A)  C57BL/10;  (A) 
B10.A. 
The most striking observation can be drawn from the data enclosed within the 
boxes in Table I. Whereas the C57BL/10 mice and B10.A mice made comparable 
amounts of antibodies specific for the 1-126 region, the C57BL/10 mice made far 
less antibody specific for the 99-149 region, so that the ratio of the two antibody 
subpopulations was markedly different for the two strains. This observation has 
been confirmed for a  second group of mice  (Fig.  3).  Since the two strains are 
congenic, presumably differing only for the H-2  complex, one can conclude that 
genes  in  the  H-2  complex can  control the  relative proportions of antibodies 
produced to two regions of a  single antigen molecule. 
A second observation is apparent from a comparison of the data for the B10.A 
and A/J strains  (Table I) which share the same "high responder" H-2 a  haplo- 
type. The large difference in total antinuclease between these two strains, which 
we have attributed to non-H-2-1inked genes (1) was primarily in the relative 
concentrations of antibodies binding to the fragment (1-126), particularly in the 
initial  response.  This  observation raises  the  possibility  that  some  non-H-2- 
linked gene(s) influence the specificity for different determinants on the same 
antigen as well, rather than merely the overall magnitude of the response. In 
addition, the highest affinities of antibodies measurable in hyperimmune anti- 
nuclease  sera  of the  two  strains  for fragment  (1-126)  differ by  an  order  of 
magnitude (1.6  x  107 M -1 for B10.A compared to 1.6 x  10  s M -~ for A/J), whereas 
the highest affinities for fragment (99-149) are similar in the two strains (about 
2-3 ×  107 M-l). It is interesting that the higher responder has the lower affinity 
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T~LE I 
Concentrations of  Antibodies to Subregions  of Nuclease in Antisera to Native Nuclease 
Bleed  Strain 
Antibody binding sites,  p_M  Ratio 
Total antinu-  anti-(99-149)/ 
clease  Anti-(99-149) Anti-(i-126)  anti-(I-126) 
1  ° 
5  ° 
F 
C57BL/10  0.38  [ 0.00 +_ 0.01  0.61 ± 0.08  0.00 _+ 0.02 
B10.A  1.35  / 0.34 ± 0.08  0.81 -  0.11  0.42  ±  0.11 
A/J  5.6  0.58 
SJL  2.2  0.6 
4.95 ± 0.35  0.12 
C57BL/10  3.9  0.26 -+ 0.03  1.2 ± 0.15  0.22 +- 0.04 
B10.A  3.7  0.71 ÷ 0.03  0.80 ± 0.12  0.89 +_ 0.14 
A/J  30.2  5.75 -+ 0.3  12.7 ± 0.55  0.45 _+ 0.03 
SJL  28.8  3.76 ± 0.7 
Concentrations of antibodies specific for given regions were obtained as the mean concentration of 
bound antigen  for the several points judged to be on the plateau of saturation  binding curves 
similar to those in Fig. 3 and 4. The standard  error of the mean for these plateau points was used 
as an estimate of  the experimental uncertainty.  All binding curves were carried out on pooled sara 
from 5 to 12 mice. Concentrations of  tetal antinuclease were estimated from the enzyme inhibition 
assay (Materials and Methods). 
The table  also lists  an  estimate  of the  total  concentration of antibodies  to 
whole nuclease in these sera.  However, since these values were obtained by a 
different method from those for antibodies binding to fragments (under different 
assay conditions,  measuring  antibodies  of a  different  range  of affinities  and 
measuring  only  inactivating  antibodies),  the  numbers  may  not  be  directly 
comparable. However, it is worth noting that the estimated total antinuclease is 
generally larger than the sum of the subpopulations binding to the two frag- 
ments, even though these subpopulations should overlap. A  likely explanation 
is that since the affinity for the random conformation fragments should be about 
103-fold  less  than  for  the  native  structure  (4),  antibodies  to  nuclease  with 
affinities  for the  native  protein  below  about  107  M-'  will  not  be  detected  in 
binding to the  fragments.  Therefore,  the  observations made  earlier  from the 
data in this table apply only to the higher affinity 40-50% of the antibodies. 
Test  for  Possible  Anti-Random  Fragment  Antibodies  in  the  BIO.A  Anti- 
Native Nuclease.  To assess the possibility that some of the greater binding of 
B10.A antinuclease  to fragment (99-149)  relative to that of C57BL/10 antinu- 
clease  was  due  to  the  presence  in  the  former  of antibodies  to  the  random 
conformation fragment which would not be expected to be made by the C57BL/10 
animals (see accompanying paper) (1), a competition experiment was carried out 130  Ho2-LINKED  CONTROL  OF  ANTINUCLEASE  SPECIFICITIES 
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FZG. 5.  Competition of native nuclease against '4C-fragment (99-149) for binding to hyper- 
immune B10.A antinuclease. Serum was that described in Fig. 2 (right panel), used at a 
constant dilution of 1:5 (about 8 × 10  -7 M in binding sites). A constant final concentration of 
2  x  10 -7 M  '4C-fragment (99-149) was mixed with the increasing final concentrations of 
native nuclease shown on the abscissa before the addition of antiserum. The ordinate is 
bound/free labeled fragment. 
(Fig. 5). The smooth curve obtained is suggestive of a reasonably homogeneous 
population of antibodies for which the lower limit of  affinity  2 for native nuclease 
is about 106 M-'. These data allow us to rule out the presence of a  significant 
concentration of anti-random-conformation-fragment antibodies by the follow- 
ing criteria: (a) The curve approaches B/F =  0 at high nuclease concentrations. 
Ifa significant fraction of  the antibodies binding to '~C-fragment (99-149) were to 
random conformation determinants not present on native nuclease, the curve 
would be expected to plateau at some value above zero, as found by Curd et al. 
(7) for antibodies to a fragment of hemoglobin S. (b) No significant fraction of 
antibodies (i.e., <10%) show a transition corresponding to an affinity of less than 
3  x  10  ~ M-L  If anti-random-conformation-fragment antibodies  were  present 
which bound to the  '4C-fragment (99-149) with an affinity of 107  (the highest 
affinity detected by Scatchard  analysis of this  same  serum's binding to  '4C- 
fragment [99-149], in Fig. 2), then according to the conformational equilibrium 
constant of  about 3 × 10  -4 found for native nuclease by Furie et al. (8) using anti- 
random conformation antibodies, the apparent affinity of these antibodies for 
native nuclease would be only about 3 x  103 M-'. Thus, these results rule out the 
production of anti-fragment antibodies by, for example, enzymatic digestion of 
We  cannot determine affinities higher than  about  106  M-'  in this  system because of the 
concentrations of labeled fragment and antiserum necessary to obtain sufficient bound radioactiv- 
ities to count. In addition, an exact assessment  of affinity is limited by the fact that the anti-native 
nuclease serum contains antibodies to determinants on whole nuclease outside the region from 
residues 99 to 149. However, the total available nuclease on the abscissa represents an overestima- 
tion, since some of the nuclease is bound by these other antibodies irrelevant to the competition 
with fragment (99-149). Therefore, the lower limit of affinity may be several-fold higher than 106 
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the nuclease during antigen "processing," as an explanation of the difference in 
specificity of B10.A and C57BL/10 antinuclease. 
The Class of Immunoglobulin Comprising the C57BL/10 Antinuclease Anti- 
bodies.  To  assess  whether  the  C57BL/10  mice,  whose  overall  antinuclease 
response after boosting had reached the same level as that of the B10.A mice, 
might have continued to manifest an Ir-gene defect by failure to switch from 
IgM to  IgG production,  we fractionated  an  aliquot  of hyperimmune  (fourth- 
bleed) C57BL/10 antinuclease  on a  Sephadex G-200 column into IgM and IgG 
fractions. After concentration by vacuum dialysis to approximately the original 
volume of serum, the IgG peak had about 70% of the original activity, whereas 
the IgM peak had no detectable activity in the nuclease inhibition assay. Thus, 
the hyperimmune C57BL/10 antinuclease response is mostly, or all, in the form 
of IgG. 
Discussion 
In the accompanying paper  (1) we demonstrated a  striking difference in the 
overall antibody response to nuclease between the A/J and B10.A strains, which 
share the same high-responder H-2 a haplotype. The difference was attributed to 
non-H-2-1inked genetic effects. The current results raise the question of  whether 
the non-H-2-1inked control has some specificity with regard to different determi- 
nants on nuclease because of the much greater contribution of anti-(i-126) than 
anti-(99-149) in accounting for the differences between these strains. In addition, 
the affinity of the lower responder B10.A antinuclease sera for fragment (1-126) 
is 10-fold higher than that of the higher responder A/J. In this regard the non-H- 
2-1inked control may be different from that described for the response to poly-(L- 
Glu, L-Ala, L-Tyr) by Dorf et al. (9) in these same strains, in which an influence 
on the magnitude but not the specificity or affinity of the antibody response was 
demonstrated. 
A  more clear-cut comparison is the contrast of the low responder C57BL/10 
strain  (H-2 b)  with the  congenic  high  responder  strain  B10.A  (H-2a).  In the 
accompanying paper  it was seen that  this  distinction  between high  and  low 
overall response to nuclease, defined for the initial antisera, disappears after the 
animals are immunized several times (1). The present results show that if one 
looks at only those antinuclease antibodies which react with the fragment (99- 
149),  the distinction between the B10.A and C57BL/10 persists even after five 
immunizations.  The C57BL/10 remains a poor respender to determinants in this 
region even though its overall response to nuclease is the same as that of the 
B10.A after boosting. The increase of the C57BL/10 response to nuclease to the 
levels of the B10.A thus represents an increase in antibodies with specificities 
for determinants outside the 99 to 149 region. The H-2-1inked Ir-gene defect in 
the  C57BL/10  appears  to  be  specific  for  determinant(s)  in  the  region  from 
residues 99 to 149. 
This  conclusion  is  especially interesting  in  light  of the  observation in  the 
accompanying  paper  (1)  that  when  the  fragments  themselves  are  used  as 
immunogens, it is the fragment (99-149) which appears to be under the same H- 
2-1inked  control  as  whole  nuclease,  and  for  which  the  C57BL/10  vs.  B10.A 
difference appears to be all-or-none. 
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than the number of antigens found under control to date would suggest, but that 
the complexity of the response to multi-determinant  antigens can easily mask 
this control for many antigens. 
Finally,  a  significant  implication  of this  study is that  in  congenic  strains 
which have the same repertoire of potential structural genes for immunoglobu- 
lin  variable regions but presumably differ only at H-2,  the H-2-1inked genes 
may control the relative  antibody responses to different determinants  on the 
same  antigen  molecule.  Two  of the  possible  alternative  mechanisms  which 
might explain the data have been ruled out: 
(a)  One possible explanation of the difference in specificities of C57BL/10 and 
B10.A antinuclease is that some of the nuclease immunogen is digested in vivo 
into random conformation fragments,  among which the B10.A responds to the 
fragment (99-149) and the C57BL/10 does not (1). This digestion apparently does 
not occur in the goat, since immunization with native nuclease yields antibodies 
which cross-react with random conformation fragments with only 0.02% of the 
affinity for the native protein  (4). The present study excludes digestion as the 
explanation of the differences observed in the mouse, since at least 90% of the 
antibodies reacting with 14C-fragment  (99-149) in the B10.A hyperimmune an- 
tinuclease are indeed anti-native  nuclease antibodies (Fig. 5). 
(b)  Another possible difference between the C57BL/10 and B10.A antibodies 
would be a  failure of the low responder C57BL/10 to switch from IgM to IgG 
production,  even though the overall magnitude  of its response reaches that of 
the B10.A with boosting. We have also ruled out this possibility by fractionation 
of the C57BL/10 antibodies on Sephadex G-200. Most or all of the antinuclease 
activity was  IgG.  This  has  also been found true  for the  B10.A  antinuclease 
serum 3 wk after a single immunization  in complete Freund's adjuvant. 
Therefore we conclude that in congenic strains of mice, H-2-1inked genes can 
control the antibody response to different determinants on the same immunogen 
molecule  separately  from  one  another.  Since  these  strains  have  the  same 
potential B-cell antibody production capabilities,  at least in terms of variable- 
region  structural  genes,  the  H-2-1inked Ir-gene  control  would  appear  to  be 
exerted  at the  level of selection of specific B  cells.  This  result raises  serious 
doubt about the notion that all that is necessary for an antibody response is the 
presence of T cells which can recognize a  ~carrier" determinant on the antigen 
molecule and through this present the antigen  molecule to B ceils specific for 
any ~haptenic"  determinant  on the molecule (10).  Since the C57BL/10 makes 
antibodies to the region of nuclease from residues 1 to 126, it must have T cells 
which can recognize a "carrier" determinant on nuclease. Then, since this strain 
should possess the same B-cell variable region potential as the B10.A, it should 
be capable of making antibodies to the 99 to 149 region. The fact that the C57BL/ 
10 does not follow this behavior implies that the H-2-1inked Ir-gene control must 
also be exerted at a  step in which specific B cells are selected. 
There  are  two general  classes of mechanism  which might  account for this 
behavior:  (a)  At  the  antigen  level,  there  may  be  more  than  one  "carrier" 
determinant  on the same molecule such that each carrier  determinant  could 
function  effectively with  only  some  of the  "haptenic"  determinants  on  the 
molecule. Some suggestion that the hapten and carrier functions are located in 
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response to the isolated fragment as immunogen appears to be under the same 
Ir-gene control as the response to whole nuclease  (1),  and it is this region to 
which antibody production is under H-2-1inked control in the native nuclease 
molecule. Moreover, in a T-cell proliferation assay, the same region appears to 
be the important one in stimulation of the B10.A mice (R. H. Schwartz, J.  A. 
Berzofsky, A. N. Schechter,  and D. H. Sachs, manuscript in preparation).  This 
closeness of carrier and hapten function also makes it unlikely that the mecha- 
nism by which a carrier cannot service some of  the haptenic determinants on the 
molecule is merely steric hindrance  due to proximity of the haptenic determi- 
nant to the site by which the antigen molecule is bound to the T-cell receptor. 
Thus, rather than to postulate several carrier regions servicing several nearby 
haptenic  regions,  it seems more reasonable  to suggest that  the  same groups 
serve both functions for natural globular proteins. 
(b) Alternatively, at the cellular level, to explain H-2 linked Ir-gene control in 
selection of B  cells of certain  specificities and not others,  one would have to 
postulate some H-2-1inked gene product which was clonally distributed among B 
cells along with the immunoglobulin variable regions, so that selection of these 
B cells on an H-2.1inked basis within a single animal could occur. No H-2 gene 
product has yet been found to be clonally distributed within a  population of B 
cells of a  homozygous inbred strain.  However, such is not impossible since the 
expression of Ia antigens may be affected differently during differentiation of 
different  subpopulations  of lymphocytes  (e.g.,  I-J  region  Ia  antigens  on  a 
subpopulation ofT cells [11]). This H-2 gene product would not necessarily have 
to be able to recognize antigen,  i.e. be a  second antigen-specific receptor on B 
cells, as long as it was clonally distributed with antigen receptors. It is conceiv- 
able then that  this  product would be concerned  with  cooperative interaction 
between B cells and helper (or suppressor) T cells, but be distributed on B and T 
cells such that only certain B  and T  cells could interact with one another in a 
single  animal.  This  restriction  is distinct  from  requirements  for cooperative 
interaction between T and B cells of different strains  (12). 
Bluestein et al. (13) observed a similar phenomenon in studying antibodies to 
poly-~-[L-glutamic  acid  (60%),  L-alanine  (30%),  L-tyrosine  (10%)]  CGAT")  in 
guinea pigs.  Both strain  2 and  strain  13 guinea pigs responded to GAT,  but 
strain  2 responded to GA  (poly[L-Glu,  L-Ala]),  and  not to GT (poly[L-Glu,  L- 
Tyr]), whereas strain 13 responded to GT and not GA. When antibodies to GAT 
were studied for binding  to GA and  GT,  strain  2 but not strain  13  anti-GAT 
reacted with GA, consistent with the phenomenon described for nuclease here. 
However, both strain 2 and 13 anti-GAT reacted well with GT, so the conclusion 
regarding the GA result was hard to interpret.  Moreover, since strain 2 and 13 
guinea pigs are not congenic, it was not possible to attribute the differences with 
certainty to major histocompatibility complex genes. 
Similarly,  Mozes  et  al.  (14)  showed  that  SJL  and  DBA/1  strains  of mice 
responded to different determinants on poly(Phe,Glu)-poly-Pro--poly-Lys. How- 
ever, these two strains of mice are not congenic, and the control of the response 
to the poly-Pro--poly-Lys determinant has been found to be non-H-2-1inked (the 
so-called Ir-3 gene) (14). 
The use of congenic strains in the current study reduces the possibility that 
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complex. A potential question regarding the genetics might be the possibility of 
genetic drift in non-H-2  (e.g.,  immunoglobulin  structural)  genes between the 
B10.A and its ancestor C57BL/10. Genetic experiments are currently in progress 
to test this possibility. 
The larger question, of whether this H-2-1inked Ir-gene control of selection of 
specific B cells is exerted at the antigen level or the cellular level as discussed, 
awaits new experimental  approaches. 
Summary 
The relative proportions of antibodies of different specificities within antisera 
raised to native staphylococcal nuclease have been studied in several strains of 
mice in which the antibody response has been shown to be under H-2-1inked Ir- 
gene control. A method was developed in which binding to different radiolabeled 
fragments of nuclease was titrated  against increasing fragment concentration 
until the binding capacity of the antiserum for that fragment was saturated.  In 
comparing  the  low responder  (H-2 b)  strain  C57BL/10 with  its  congenic  high 
responder  counterpart  B10.A (H-2"),  it was found that  the two strains  made 
markedly and reproducibly different proportions of antibodies to different deter- 
minants  on native  nuclease.  Since these  two strains  differ only at H-2,  and 
therefore have identical  immunoglobulin  structural  gene repertoires,  we con- 
clude that H-2-1inked Ir genes can control the response to different determinants 
on the same antigen  molecule independently of one another.  This result sug- 
gests a possible role of H-2-1inked genes in the selection of specific B cells. 
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